376 related articles for article (PubMed ID: 25863119)
1. Development of mucoadhesive sprayable gellan gum fluid gels.
Mahdi MH; Conway BR; Smith AM
Int J Pharm; 2015 Jul; 488(1-2):12-9. PubMed ID: 25863119
[TBL] [Abstract][Full Text] [Related]
2. Gellan gum fluid gels for topical administration of diclofenac.
Mahdi MH; Conway BR; Mills T; Smith AM
Int J Pharm; 2016 Dec; 515(1-2):535-542. PubMed ID: 27789369
[TBL] [Abstract][Full Text] [Related]
3. A gellan-based fluid gel carrier to enhance topical spray delivery.
Ter Horst B; Moakes RJA; Chouhan G; Williams RL; Moiemen NS; Grover LM
Acta Biomater; 2019 Apr; 89():166-179. PubMed ID: 30904549
[TBL] [Abstract][Full Text] [Related]
4. Ion activated in situ gel of gellan gum containing salbutamol sulphate for nasal administration.
Salunke SR; Patil SB
Int J Biol Macromol; 2016 Jun; 87():41-7. PubMed ID: 26899173
[TBL] [Abstract][Full Text] [Related]
5. Rheology of sheared gels based on low acyl-gellan gum.
García MC; Alfaro MC; Muñoz J
Food Sci Technol Int; 2016 Jun; 22(4):325-32. PubMed ID: 26251462
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of gellan gum fluid gels as modified release oral liquids.
Mahdi MH; Conway BR; Smith AM
Int J Pharm; 2014 Nov; 475(1-2):335-43. PubMed ID: 25169076
[TBL] [Abstract][Full Text] [Related]
7. Formulation and evaluation of in situ gelling systems for intranasal administration of gastrodin.
Cai Z; Song X; Sun F; Yang Z; Hou S; Liu Z
AAPS PharmSciTech; 2011 Dec; 12(4):1102-9. PubMed ID: 21879392
[TBL] [Abstract][Full Text] [Related]
8. Ion-activated
Lavania K; Garg A
Recent Adv Drug Deliv Formul; 2024; 18(1):35-49. PubMed ID: 38058093
[TBL] [Abstract][Full Text] [Related]
9. Development of in situ gel for nasal delivery: design, optimization, in vitro and in vivo evaluation.
Galgatte UC; Kumbhar AB; Chaudhari PD
Drug Deliv; 2014 Feb; 21(1):62-73. PubMed ID: 24191774
[TBL] [Abstract][Full Text] [Related]
10. Formulation and evaluation of in situ gelling system of dimenhydrinate for nasal administration.
Belgamwar VS; Chauk DS; Mahajan HS; Jain SA; Gattani SG; Surana SJ
Pharm Dev Technol; 2009; 14(3):240-8. PubMed ID: 19235555
[TBL] [Abstract][Full Text] [Related]
11. Improvement in the in situ gelling properties of deacetylated gellan gum by the immobilization of thiol groups.
Krauland AH; Leitner VM; Bernkop-Schnürch A
J Pharm Sci; 2003 Jun; 92(6):1234-41. PubMed ID: 12761812
[TBL] [Abstract][Full Text] [Related]
12. Innovative sprayable in situ gelling fluticasone suspension: Development and optimization of nasal deposition.
Nižić L; Ugrina I; Špoljarić D; Saršon V; Kučuk MS; Pepić I; Hafner A
Int J Pharm; 2019 May; 563():445-456. PubMed ID: 30965121
[TBL] [Abstract][Full Text] [Related]
13. Preparation of ion-activated in situ gel systems of scopolamine hydrobromide and evaluation of its antimotion sickness efficacy.
Cao SL; Zhang QZ; Jiang XG
Acta Pharmacol Sin; 2007 Apr; 28(4):584-90. PubMed ID: 17376300
[TBL] [Abstract][Full Text] [Related]
14. Particle stability in dilute fermented dairy drinks: formation of fluid gel and impact on rheological properties.
Kiani H; Mousavi ME; Mousavi ZE
Food Sci Technol Int; 2010 Dec; 16(6):543-51. PubMed ID: 21339170
[TBL] [Abstract][Full Text] [Related]
15. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties.
Zaki NM; Awad GA; Mortada ND; Abd Elhady SS
Eur J Pharm Sci; 2007 Dec; 32(4-5):296-307. PubMed ID: 17920822
[TBL] [Abstract][Full Text] [Related]
16. Surfactant systems for nasal zidovudine delivery: structural, rheological and mucoadhesive properties.
Carvalho FC; Barbi MS; Sarmento VH; Chiavacci LA; Netto FM; Gremião MP
J Pharm Pharmacol; 2010 Apr; 62(4):430-9. PubMed ID: 20604831
[TBL] [Abstract][Full Text] [Related]
17. Rheological investigation of high-acyl gellan gum hydrogel and its mixtures with simulated body fluids.
Osmałek TZ; Froelich A; Jadach B; Krakowski M
J Biomater Appl; 2018 May; 32(10):1435-1449. PubMed ID: 29534627
[TBL] [Abstract][Full Text] [Related]
18. Optimization of a novel in situ gel for sustained ocular drug delivery using Box-Behnken design: In vitro, ex vivo, in vivo and human studies.
Ranch KM; Maulvi FA; Naik MJ; Koli AR; Parikh RK; Shah DO
Int J Pharm; 2019 Jan; 554():264-275. PubMed ID: 30423418
[TBL] [Abstract][Full Text] [Related]
19. Novel in situ gelling ophthalmic drug delivery system based on gellan gum and hydroxyethylcellulose: Innovative rheological characterization, in vitro and in vivo evidence of a sustained precorneal retention time.
Destruel PL; Zeng N; Seguin J; Douat S; Rosa F; Brignole-Baudouin F; Dufaÿ S; Dufaÿ-Wojcicki A; Maury M; Mignet N; Boudy V
Int J Pharm; 2020 Jan; 574():118734. PubMed ID: 31705970
[TBL] [Abstract][Full Text] [Related]
20. Nasal drug delivery: Design of a novel mucoadhesive and in situ gelling polymer.
Menzel C; Jelkmann M; Laffleur F; Bernkop-Schnürch A
Int J Pharm; 2017 Jan; 517(1-2):196-202. PubMed ID: 27890621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
